- Ike Iheanacho, editor, Drugs and Therapeutics Bulletin
- iiheanacho{at}bmjgroup.com
A trillion here, a trillion there, and pretty soon you’re talking real money. The original version of this maxim (“A million here, a million there . . .”), usually cited as the words of the late US senator Everett Dirksen in the 1960s, remains a beautifully sarcastic condemnation of careless spending. But obviously it’s also out of date, partly owing to the ravages of inflation. Today even a billion of any currency barely has the power to shock or awe, albeit that (or perhaps because) these sums are way outside the experience or understanding of most people.
So the received wisdom that it now takes more than a billion dollars to develop a new drug might provoke yawns not gasps, particularly in a macroeconomic climate where finance ministers …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record








Social bookmarking